APOA1 and inherited lipid metabolism disorder: Patients treated with statins in our cohort had increased ApoA1; however, this analysis was underpowered and could have been an artefact of increased statin use in the older patient group where ApoA1 was naturally higher, matching the increase in clinical dyslipidaemia with age observed in our cohort.